• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】41713

【品名】(1S,2R)-1-[[(4-methylphenyl)sulfonyl]amino]-2,3-dihydro-1H-inden-2-yl (2S,3S,4E)-2-hexyl-3-hydroxy-5-phenyl-4-pentenoate

【CA登记号】

【 分 子 式 】C33H39NO5S

【 分 子 量 】561.7424

【元素组成】C 70.56% H 7% N 2.49% O 14.24% S 5.71%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(V)

A new asymmetric synthesis of orlistat has been described: Reaction of the chiral aminoindanol (I) with octanoyl chloride (II) in pyridine gives the chiral ester (III), which is condensed with cinnamaldehyde (IV) by means of TiCl4, DIEA and Bu2BOTf in dichloromethane yielding, after chromatographic purification, the anti-aldol adduct (V). Hydrolysis of the chiral auxiliary of (V) with lithium hydroperoxide affords the beta-hydroxy acid (VI), which is protected as the 1,3-dioxan-4-one (VIII) by reaction with pivalaldehyde (VII), TMS-OTf and isopropoxytrimethylsilane (TMS-O-i-Pr). Ozonolysis of (VIII) with O3 in dichloromethane yields the aldehyde (IX), which is condensed with 1-nitrododecane (X) by means of TBAF in DMF to provide the nitroaldol (XI). The dehydration of (XI) with DCC and CuCl in hot acetonitrile gives the nitroalkene (XII), which is reduced with Zn/HOAc to oxime (XIII). Oxidative hydrolysis of (XIII) with ceric ammonium nitrate (CAN) and HNO3 yields diketone (XIV), which is hydrolyzed with HCl in THF providing the beta-hydroxy acid (XV). Esterification of (XV) with benzyl iodide and CsCO3 gives the benzyl ester (XVI), which is estereoselectively reduced with Me4NB(OAc)3H in HOAc/acetonitrile yielding the chiral anti-1,3-diol (XVII). The selective protection of (XVII) with TIPS-OTf and 2,6-lutidine affords the monosilylated ester (XVIII), which is treated with H2 over Pd(OH)2 in ethyl acetate/methanol to furnish the free beta-hydroxy acid (XIX). Cyclization of acid (XIX) by means of PhSO2Cl in pyridine affords the beta-lactone (XX), which is desilylated with TBAF and HOAc in THF giving lactone (XXI). Finally, lactone (XXI) is esterified under Mitsunobu conditions with N-formyl-L-leucine (XXII) by means of DIAD and PPh3 in THF.

1 Ghosh, A.K.; Fidanze, S.; Asymmetric synthesis of (-)-tetrahydrolipstatin: An anti-aldol-based strategy. Org Lett 2000, 2, 16, 2405.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 41710 N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-4-methylbenzenesulfonamide C16H17NO3S 详情 详情
(II) 11091 Octanoic acid 124-07-2 C8H16O2 详情 详情
(III) 41711 (1S,2R)-1-[[(4-methylphenyl)sulfonyl]amino]-2,3-dihydro-1H-inden-2-yl octanoate C24H31NO4S 详情 详情
(IV) 41712 (E)-3-phenyl-2-propenal 14371-10-9 C9H8O 详情 详情
(V) 41713 (1S,2R)-1-[[(4-methylphenyl)sulfonyl]amino]-2,3-dihydro-1H-inden-2-yl (2S,3S,4E)-2-hexyl-3-hydroxy-5-phenyl-4-pentenoate C33H39NO5S 详情 详情
(VI) 41714 (2S,3S,4E)-2-hexyl-3-hydroxy-5-phenyl-4-pentenoic acid C17H24O3 详情 详情
(VII) 19797 Trimethylacetaldehyde; pivalaldehyde; 2,2-Dimethylpropionaldehyde; 2,2-Dimethylpropanal 630-19-3 C5H10O 详情 详情
(VIII) 41715 (2S,5S,6S)-2-(tert-butyl)-5-hexyl-6-[(E)-2-phenylethenyl]-1,3-dioxan-4-one C22H32O3 详情 详情
(IX) 41716 (2S,4R,5S)-2-(tert-butyl)-5-hexyl-6-oxo-1,3-dioxane-4-carbaldehyde C15H26O4 详情 详情
(X) 41717 1-nitroundecane C11H23NO2 详情 详情
(XI) 41718 (2S,5S,6R)-2-(tert-butyl)-5-hexyl-6-(1-hydroxy-2-nitrododecyl)-1,3-dioxan-4-one C26H49NO6 详情 详情
(XII) 41719 (2S,5S,6S)-2-(tert-butyl)-5-hexyl-6-[(E)-2-nitro-1-dodecenyl]-1,3-dioxan-4-one C26H47NO5 详情 详情
(XIII) 41720 (2S,5S,6S)-2-(tert-butyl)-5-hexyl-6-[2-(hydroxyimino)dodecyl]-1,3-dioxan-4-one C26H49NO4 详情 详情
(XIV) 41721 (2S,5S,6S)-2-(tert-butyl)-5-hexyl-6-(2-oxododecyl)-1,3-dioxan-4-one C26H48O4 详情 详情
(XV) 41722 (2S,3S)-2-hexyl-3-hydroxy-5-oxopentadecanoic acid C21H40O4 详情 详情
(XVI) 41723 benzyl (2S,3S)-2-hexyl-3-hydroxy-5-oxopentadecanoate C28H46O4 详情 详情
(XVII) 41724 benzyl (2S,3S,5R)-2-hexyl-3,5-dihydroxypentadecanoate C28H48O4 详情 详情
(XVIII) 41725 benzyl (2S,3S,5R)-2-hexyl-3-hydroxy-5-[(triisopropylsilyl)oxy]pentadecanoate C37H68O4Si 详情 详情
(XIX) 41726 (2S,3S,5R)-2-hexyl-3-hydroxy-5-[(triisopropylsilyl)oxy]pentadecanoic acid C30H62O4Si 详情 详情
(XX) 41727 (3S,4S)-3-hexyl-4-[(2R)-2-[(triisopropylsilyl)oxy]dodecyl]-2-oxetanone C30H60O3Si 详情 详情
(XXI) 41728 (3S,4S)-3-hexyl-4-[(2R)-2-hydroxydodecyl]-2-oxetanone C21H40O3 详情 详情
(XXII) 11081 N-Formyl-L-leucine; (2S)-2-(Formylamino)-4-methylpentanoic acid 6113-61-7 C7H13NO3 详情 详情
Extended Information